anidulafungin has been researched along with fusarium in 7 studies
| Studies (anidulafungin) | Trials (anidulafungin) | Recent Studies (post-2010) (anidulafungin) | Studies (fusarium) | Trials (fusarium) | Recent Studies (post-2010) (fusarium) |
|---|---|---|---|---|---|
| 568 | 33 | 331 | 12,546 | 60 | 6,356 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Jones, RN; Marco, F; Messer, SA; Pfaller, MA | 1 |
| Chen, E; Odabasi, Z; Ostrosky-Zeichner, L; Paetznick, VL; Philip, A; Rex, JH; Rodriguez, J | 1 |
| Cantón, E; Castro, C; González, A; González, MT; Martín-Mazuelos, E; Martos, AI; Pemán, J; Romero, A; Serrano, C | 1 |
| Castanheira, M; Diekema, DJ; Duncanson, FP; Guarro, J; Jones, RN; Pfaller, MA | 1 |
| Chan, TS; Chim, CS; Gill, H; Hwang, YY; Khong, PL; Kwong, YL; Leung, AY; Lie, AK; Loong, F; Sim, J; Tse, AC; Tse, E | 1 |
| Schnadig, VJ; Shah, SK; Terasaki, JM; Valentine, VG | 1 |
| Hamor, RE; Martinez, PS; Plummer, CE; Richardson, RL; Wellehan, JFX; Whitley, RD | 1 |
7 other study(ies) available for anidulafungin and fusarium
| Article | Year |
|---|---|
In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi.
Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Aspergillus; Caspofungin; Echinocandins; Fungi; Fusarium; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Rhizopus | 1998 |
In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus; Drug Synergism; Echinocandins; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins.
Topics: Anidulafungin; Antifungal Agents; Aspergillus; Caspofungin; Echinocandins; Fusarium; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycology | 2010 |
Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods.
Topics: Acylation; Aminopyridines; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Fusarium; Glycosylphosphatidylinositols; Humans; Inositol; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2012 |
Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patients.
Topics: Adenine Nucleotides; Adult; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Antimetabolites, Antineoplastic; Arabinonucleosides; Candida; Candidiasis, Invasive; Caspofungin; China; Clofarabine; Cohort Studies; Cross Infection; Echinocandins; Fusariosis; Fusarium; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Lipopeptides; Lung Diseases, Fungal; Micafungin; Retrospective Studies; Risk Factors | 2014 |
Airway complication contributing to disseminated fusariosis after lung transplantation.
Topics: Aged; Anidulafungin; Antifungal Agents; Drug Therapy, Combination; Echinocandins; Female; Fusariosis; Fusarium; Humans; Lung Diseases, Fungal; Lung Transplantation; Voriconazole | 2014 |
In vitro antifungal susceptibility of Fusarium species and Aspergillus fumigatus cultured from eleven horses with fungal keratitis.
Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillus fumigatus; Corneal Ulcer; Echinocandins; Eye Infections, Fungal; Fusarium; Horses; Microbial Sensitivity Tests; Natamycin; Voriconazole | 2022 |